No CrossRef data available.
Article contents
Antidepressant quandaries
Published online by Cambridge University Press: 03 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Columns
- Information
- Copyright
- Copyright © 1998 The Royal College of Psychiatrists
References
Greenberg, R. P., Bornstein, R. F., Zborowski, M. J., et al (1994) A meta-analysis of fluoxetine outcome in the treatment of depression. Journal of Nervous and Mental Disease, 182, 517–551.Google Scholar
Greenberg, R. P. & Fisher, S. (1989) Examining antidepressant effectiveness: Findings, ambiguities, and some vexing puzzles. In The Limits of Biological Treatments for Psychological Distress: Comparisons with Psychotherapy and Placebo (eds Fisher, S. & Greenberg, R. P.), pp. 1–37, Hillsdale, NJ: Ertbaum.Google Scholar
Greenberg, R. P. & Fisher, S. (1997) Mood-mending medicines: probing drug, psychotherapy and placebo solutions. In From Placebo to Panacea: Putting Psychiatric Drugs to the Test (eds Fisher, S. & Greenberg, R. P.), pp. 115–172. New York: Wiley.Google Scholar
Huty, D. (1991) Commentary: Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 171, 232–234.Google Scholar
Moncrieff, J., Wesseley, S. & Hardy, R. (1998) Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 172, 227–231.Google Scholar
You have
Access
eLetters
No eLetters have been published for this article.